Vita means life. It's also our platform for sharing the stories of biotech's promise to patients and public health.
CSL consists of CSL Behring, CSL Seqirus and CSL Vifor. Learn more by visiting each section.
Biotechnology leader CSL Behring offers the broadest range of quality plasma-derived and recombinant therapies in our industry.
Derived from the expression 'securing health for all of us', CSL Seqirus is one of the world's largest influenza vaccine providers.
R&D focuses its expertise on four strategic platforms: plasma protein technology; recombinant technology; cell and gene therapy; and vaccines technology.
One of our core values at CSL is Innovation. We support collaborative innovation through the endowment of awards and grants to researchers around the world.
As part of our broader sustainability strategy to build a more sustainable future, we've committed to a 40% reduction in absolute Scope 1 and 2 emissions by 2030.
Along with our sustainability strategy, CSL’s community contribution framework helps deliver on our Values and support execution of our 2030 strategy.
At CSL, Diversity, Equity, and Inclusion (DEI) is at the core of our mission and who we are. It fuels our innovation day in and day out.
Whether you are early in your college education or recently completed your degree, it's never too soon to consider CSL for your Promising Future!
Hemophilia A and B can have similar symptoms, but their underlying causes and potential treatments differ.
Tim Grams, father of four, dove into swimming as a young person and today stays active despite Hemophilia A.
CSL recognizes patients around the globe who live with bleeding disorders such as hemophilia. Continued innovation and improv…
Dr. Shirley Abraham, who heads a Hemophilia Treatment Center in New Mexico, answers three important questions for parents.
As hemophilia patients live longer lives, watch out for these three health conditions, according to a recent Hemophilia Feder…
CSL Behring sponsors an independent report that charts decades of progress in treating hemophilia and von Willebrand disease …
A photo exhibit featuring hemophilia patients, caregivers and health care providers expands its focus.
Children and teens who live with hemophilia and other bleeding disorders work hard to achieve a milestone: mastering the art …
Communications about COVID-19 go out to those living with hemophilia, von Willebrand disease.
New global data reveals the bleeding disorder is more prevalent than previously thought, according to the World Federation of…
Former pitcher and hemophilia patient Jesse Schrader on managing health.
Women with a family history of hemophilia could see symptoms like abnormal bleeding.
Americas
Asia Pacific
Middle East
Europe